Interaction of atopy and smoking on respiratory effects of occupational dust exposure: a general population-based study
© Meer et al; licensee BioMed Central Ltd. 2004
Received: 02 December 2003
Accepted: 02 June 2004
Published: 02 June 2004
For individual exposures, effect modification by atopy or smoking has been reported on the occurrence of occupational airway disease. It is unclear if effect modification can be studied in a general population by an aggregated exposure measure. Assess relationship between airway obstruction and occupational exposure using a job-exposure-matrix (JEM) classifying jobs into 3 broad types of exposure, and test for effect modification by atopy, and smoking.
Data from 1,906 subjects were analyzed, all participants of the European Community Respiratory Health Survey. Job titles were categorized by an a priori constructed job exposure matrix into three classes of exposure to respectively organic dust, mineral dust, and gases/ fumes. Relationships were assessed for 'current wheeze', bronchial hyperresponsiveness (BHR), 'current asthma' (wheeze+BHR), and 'chronic bronchitis' (morning phlegm or morning cough), and lung function.
Subjects with organic dust exposure in their work environment more frequently had 'current asthma' (OR 1.48, 95% C.I. 0.95;2.30), and a lower FEV1 (-59 mL, 95% C.I. -114;-4). The relationship was only present in asthmatic workers, and their risk was four-fold greater than in subjects with either atopy or exposure alone. Mineral dust exposure was associated with 'chronic bronchitis' (OR 2.22, 95% C.I. 1.16;4.23) and a lower FEV1/FVC ratio (-1.1%, 95% C.I. -1.8;-0.3). We observed an excess risk in smokers, greater than the separate effects of smoking or mineral dust exposure together.
Occupational exposure to organic dust is associated with an increased risk of asthma, particularly in atopics. Chronic bronchitis occurs more frequently among individuals exposed to mineral dust, and smoking doubles this risk.
Exposure to agents in the work environment may be involved in the aetiology or aggravation of asthma in adults [1–5]. The relation with chronic airway obstruction has also been recognized, but has been studied in less detail [6–8]. The mechanism of occupational asthma depends on the causal agent . An allergic immune response generally involved if the exposure constitutes of a high-molecular weight agent (e.g. latex, enzymes, animal dander) . In asthma due to low-molecular weight agents (e.g. isocyanates, anhydrides), an IgE or IgG-mediated response may be involved . Alternatively, non-specific mechanisms may occur in asthma due to exposure to irritants that mostly comprise exposure to gases or fumes . Exposures that penetrate well in the small airways (e.g. silica, coal dust, endotoxin) may result in chronic airway obstruction .
Occupational asthma is more commonly found in a topic workers, especially if exposed to agents that induce an allergic immune response [14–18]. Also smokers are more prone to develop occupational asthma [17–20]. However, only a few studies have focussed on the magnitude of the effect of a joint presence of occupational exposure and atopy  or smoking . A more precise estimate of the role of atopy and smoking in occupational asthma may provide arguments towards more specific prevention strategies.
We have studied the relationship between occupational exposure and obstructive airway disease in the Dutch contribution of the European Community Respiratory Health Survey (ECRHS). We were particularly interested in atopy and smoking as possible effect modifiers of the association between occupational exposure and obstructive airway disease.
The aims and methods of the ECRHS have been described previously . The Dutch study population consisted of a random sample of 24,017 subjects in three living areas, aged 20–70 years. Subjects aged 45–70 years were an extension of the ECRHS protocol. Subjects completed a screening questionnaire on respiratory symptoms in phase 1. In phase 2, a random sample of 4,522 subjects was invited for further examination. Subjects completed a questionnaire on respiratory symptoms, smoking, and working history, and underwent skin prick testing, blood sampling, and a bronchial challenge test with methacholine. A total of 2,711 subjects (60%) participated in phase 2. In phase 2 more men (57%) than women (44%) aged 65–70 years participated, and there was a tendency towards more wheezing (23% in responders versus 19% in non-responders) though not statistically significant. For the analyses presented in this paper, we included subjects with complete data on symptoms of airway obstruction, working history, smoking history, atopic status, and bronchial challenge test, leaving a study population of 1,906 subjects.
The present job or the jobs quitted because of respiratory symptoms were classified into 350 job titles by means of the classification of the 1980 Office of Population Census and Surveys (OPCS 1980). A population specific job-exposure matrix (JEM) was used to categorize each job title into three broad categories of agents: organic dust, mineral dust, or gases/fumes. Two occupational hygienists assessed the three types of exposure separately for each job title, and reached consensus in case of disagreement developed the JEM. The jobs were classified as not exposed, exposed to a low amount or a high amount of each of the three groups of pollutants.  For this study the groups of low and high exposed individuals were combined, because the number of highly exposed subjects limited statistical analyses.
Lung function and Bronchial Hyperresponsiveness (BHR)
Baseline lung function comprised measurement of one-second forced expiratory volume (FEV1), and forced vital capacity (FVC) with a dry seal spirometer (Morgan Spiroflow Ds12; P.K. Morgan Ltd., Rainhamm/Gillingham, Kent, UK) according to the recommendations of the European Respiratory Society .
Bronchial hyperresponsiveness (BHR) was assessed by inhalation of methacholine chloride using a Mefar dosimeter. Short acting beta agonists and anticholinergic inhaler was stopped 4 hours, and oral medication (theophylline or antimuscarinic) for 8 hours before the test. Subjects who were not able to perform successful FEV1 and FVC maneuvers or had an FEV1 less than 70% of the mean predicted value or an FEV1 less than 1.5 liters were excluded from methacholine challenge. Other exclusion criteria were a heart attack in the last 3 months, any heart disease for which medication was used, epilepsy for which medication was used, pregnancy, breast-feeding or the use of a beta-blocker.
In symptomatic subjects methacholine challenge was performed according to a long protocol of doubling the cumulative dose of methacholine after a starting dose of 7.8 μg up to a cumulative dose of 2 mg. In asymptomatic subjects a short protocol was followed in which doses were quadrupled after a starting dose of 15.6 μg. The challenge was stopped if there was a 20% fall in FEV1 from the control value in the better of two technically satisfactory manoeuvres performed after each inhalation. Bronchial hyperresponsiveness (BHR) was defined as at least 20% fall in FEV1 compared to the baseline value.
Skin prick tests (SPT) included nine inhalant allergens: D. pteronyssinus, cat, C. herbarum, timothy grass, P. judaica, Alternaria alternata, birch, olive, and ragweed (Pharmacia Diagnostics AB; Uppsala, Sweden). Serum was analyzed for specific IgE for the first five mentioned allergens above (Pharmacia CAP System; Uppsala, Sweden). A SPT was considered positive if the mean wheal diameter was 3 mm or greater, and atopy was defined as the presence of at least one positive SPT. or specific IgE > 35 kU/l for at least one allergen.
Current wheeze: Wheeze or asthma in past 12 months
Current asthma: Wheeze or asthma in past 12 months + BHR
Chronic bronchitis: Daily morning phlegm or cough for 3 months in the past 12 months
By regression analyses using the statistical package SAS 6.11, we assessed relationships between occupational exposure and respiratory health. Logistic regression analysis was applied for dichotomous outcomes 'current wheeze', 'current asthma', and 'chronic bronchitis'. Differences in pre-challenge FEV1 and FEV1 /FVC ratio were analyzed by linear regression. All regression analyses were adjusted for living area, age, sex, pack years smoking, and working years in job title used in analyses (current job or job quitted because of symptoms). This changed the estimates by maximally 10–20% of those obtained in bivariate regression analyses. Additionally, adjustment for height and weight occurred in the linear regression models on lung function. All regression models included the three types of exposure, aiming to assess independent effects.
The models included a number of correlated variables (the three exposure types, and age-related variables of pack years, working years, and age). To test for colinearity, we performed analyses with all correlated variables in the model, and separately for each correlated variable. Standard errors did not change markedly, indicating that colinearity is unlikely.
Since exposure-response relationships may depend on sex and age, we performed stratified analyses for both. In the age stratification, we aimed to compare subjects aged over 44 with the younger ones to address to extension of the Dutch sample contributing to ECRHS study population. To evaluate atopy and smoking as potential effect modifiers, we compared combined effects of occupational exposure and atopy, or smoking, with the sum of separate effects, as described by Pearce .
Population characteristics, N = 1,906
Age, mean (range)
Current smoker Ex smoker
775 (41) 508 (27)
FEV1 %predicted, mean (range)
Distribution of occupational exposure, N (%).
Organic dust and Mineral dust and gases/fumes
Airway obstruction and occupational exposure; odds ratios (OR) and 95% confidence interval (95% C.I.)
OR (95% C.I.)
OR (95% C.I.)
OR (95% C.I.)
As shown in figure 1, pre-challenge FEV1 was lower if exposed to organic dust (-63 mL, 95% C.I. -118;-8). Figure 2 shows that subjects exposed to mineral dust had a lower FEV1/FVC ratio (-1.1%, 95% C.I. -1.8;-0.3). Exclusion of subjects with current asthma for the analyses on chronic airway obstruction did not change the results.
Since occupational exposures and age related variables (pack years smoked, age, and number working years) are correlated, the regression results may have been influenced by colinearity. Excluding the correlated variables from the regression models did not change the standard errors essentially, suggesting that colinearity did not play an important role.
For subjects who left their job because of respiratory symptoms, no information was available on the nature of this symptom at that time. Therefore, we decided to consider these job titles as being at risk for all outcomes in our analyses. Excluding these subjects did not change the results markedly.
Stratified analyses for gender yielded similar results for men and women. Stratification for age yielded some significant differences between 20–44 and 45–70 year old subjects, since confidence intervals of each stratum did not include the estimate of the other stratum. Younger subjects had a lower FEV1 if occupationally exposed to organic dust (-107 mL, 95% C.I. -185;-29 versus -18 mL, 95% C.I. -96;+60). In the elderly, we observed a lower FEV1/FVC ratio if exposed to mineral dust (-1.73%, 95%C.I. -2.8;-0.6 versus -0.4%, 95% C.I. -1.4;+0.6). Furthermore, 45–70 year old subjects were more likely to have current asthma if exposed to organic dust compared to younger ones, though the difference was not statistically significant (OR45–70 = 1.86, 95% C.I. 1.04;3.32 and OR20–44 = 1.12, 95% C.I. 0.55;2.27). Similar results were found for the relationship between mineral dust exposure and chronic bronchitis (OR45–70 = 2.60, 95% C.I. 1.11;6.12 and respectively OR20–44 = 1.58, 95% C.I. 0.57;4.36).
Separate and joint effects for occupational dust exposure and atopy or smoking; odds ratios (OR) and 95% confidence interval (95% C.I.) – Current asthma, a separate and joint presence of organic dust exposure and atopy
OR (95% C.I.)
OR (95% C.I.)
Separate and joint effects for occupational dust exposure and atopy or smoking; odds ratios (OR) and 95% confidence interval (95% C.I.) – Chronic bronchitis, a separate and joint presence of mineral dust exposure and current smoking
OR (95% C.I.)
OR (95% C.I.)
In this general population study, asthma occurred more frequently and FEV1 was decreased if individuals had been exposed to organic dust in the work environment. Mineral dust exposure was associated with an increased prevalence of chronic bronchitis and a decreased FEV1/FVC ratio. Our results suggest an excess risk of asthma and chronic bronchitis in respectively atopics and smokers
The study evaluated occupational risk factors and effect modification by atopy and smoking in a general population using a job-exposure-matrix (JEM) to categorize exposure into three broad types of exposure has been used to study effect modification on occupational asthma, chronic bronchitis and lung function in a general population.
In the Dutch population, asthma occurred more often if having a job with organic dust exposure, which is consistent with other studies that used job titles [4, 5]. In our study, FEV1 was lower as well if exposed to organic dust. Moreover, our results suggest an excess risk of asthma if atopy and organic dust exposure occurred concurrently. Although atopy is considered a risk factor for occupational asthma due to high molecular weight agents, most studies are workforce based and lack statistical power to study effect modification in sufficient detail. In the ECRHS contributions of both New Zealand and Spain, atopics also had an increased risk of occupational asthma, but the risk did not exceed the sum of the separate risk estimates [4, 5]. However, these studies used job titles as a marker of occupational exposure, which may have limited statistical power to test for effect modification.
Interestingly, 20–44 year old subjects exposed to organic dust had a lower FEV1 than older subjects. In contrast, risk estimates for current wheeze, BHR and current asthma were similar for both age groups. These results suggest that lung function deterioration precedes symptoms. Indeed, the association between organic dust exposure and asthma was stronger in the elderly subjects. Alternatively, it may reflect a 'healthy worker effect' due to differential job leave of younger subjects with respiratory symptoms. Only prospective studies can properly evaluate such sources of bias. However, our study design does not allow a conclusion towards either explanation.
In our population, chronic bronchitis occurred more frequently in subjects exposed to mineral dust exposure in the work environment. In contrast to results of the Spanish contribution to the ECRHS, we did not find an association with organic dust . Inclusion of subjects over 45 years did not explain this difference, since we neither observed a relationship with organic dust exposure in the 20–45 year old group. Different sources of organic dust may play a role, as well as differences in the perception and report of symptoms, either due to biological factors or related to language.
Smokers exposed to mineral dust had excess risk of chronic bronchitis compared to the expected one by the risk estimates of smoking and mineral dust exposure separately. Others have shown similar results, but the excess risk was too small to conclude effect modification [6, 22].
Our results seem in contradiction with the results of the pooled ECRHS data, in which our population was included as well . Although the same JEM was used in the pooled ECRHS analyses, results were presented for a pooled exposure measure defined by exposure to any of the three agents. This less specific classification of occupational may have underestimated the effect. An alternative explanation is the inclusion of elderly subjects in our study population. Indeed, we observed the strongest associations in the elderly.
In this study we distinguished three types of exposure. An advantage of this approach compared to analyses by job title is an increased number of observations per exposure category resulting in a higher statistical power. However, due to loss of specificity this may result in underestimation of presented exposure-specific risks. Most job titles were categorized as being exposed to more than one type of exposure, though correlations between different exposures were low. In the analyses we made an attempt to study relationships for each exposure category by mutually adjustment for the other two categories. However, it may well be that multiple exposures interact in causing airway pathology. Unfortunately, we were unable to study such interactions because the prevalence of single exposure was too small.
Studies on occupational asthma mostly exclude the elderly to prevent possible bias by a healthy worker effect. We tried to minimise a healthy worker effect by including job titles for which symptoms were. However, a healthy worker effect cannot be completely excluded because of recall bias. Otherwise, subjects with work-related symptoms may have quitted their job, without assigning their symptoms to the job. No data were available on the nature of symptoms that had led to changing jobs. This may have led to misclassification of exposure if subjects left their job because of other respiratory symptoms than studied here (wheeze, chronic cough and phlegm). Furthermore, it limited separate analyses for asthma or chronic bronchitis for these job titles. In fact, we considered these job titles as being at risk for all heath outcomes. This may have introduced a source of bias. Though, the effect will have been marginal since job leave because of symptoms was reported by only 1% of the study population. Moreover, the results did not change after exclusion of subjects who had quitted their job because of respiratory symptoms.
Bias may have been introduced by the low response rate, since only 60% of the invited subjects participated in phase 2 of the study protocol, and data for 42% was acceptable for current analyses. If exposed subjects were more likely to participate in phase 2, our study may have overestimated the effects of occupational exposure. This would particularly be the case if exposed symptomatic subjects participated more frequently than exposed a-symptomatic subjects. The collected data only partially allowed the evaluation of selection bias. Our results did not suggest selection of symptomatic subjects, since wheeze occurred equally in subjects who participated in phase 2 and those who did not. Selection by occupational history could not be evaluated, since no information was collected on occupational history in phase 1. We emphasize that the primary focus of the study addressed to other risk factors than occupational exposure. In fact, subjects were unaware of the analysis of occupation and airway obstruction. Although we cannot completely rule out selection bias, the available information does not suggest that this will have had a major role.
Summarized, asthma occurred more frequently and FEV1 was lower in subjects exposed to organic dust in the work environment, particularly in atopic subjects. The risk of chronic bronchitis was increased, and the FEV1/FVC ratio was lower in subjects exposed to mineral dust in their job, particularly in smokers.
We conclude that atopy is an effect modifier of the relation between asthma and organic dust exposure, and smoking for chronic bronchitis and mineral dust exposure. This suggests a mechanistic pathway that amplifies the effects of occupational exposures.
List of abbreviations
job exposure matrix
European Community Respiratory Health Survey
- FEV1 :
Forced expiratory volume in 1 second
Forced vital capacity
- Johnson AR, Dimich-Ward HD, Manfreda J, Becklake MR, Ernst P, Sears MR, Bowie DM, Sweet L, Chan-Yeung M: Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med. 2000, 162: 2058-62.View ArticleGoogle Scholar
- Toren K, Balder B, Brisman J, Lindholm N, Lowhagen O, Palmqvist M, Tunsater A: The risk of asthma in relation to occupational exposures: a case-control study from a Swedish city. Eur Respir J. 1999, 13: 496-501. 10.1183/09031936.99.13349699.View ArticleGoogle Scholar
- Blanc PD, Eisner MD, Israel L, Yelin EH: The association between occupation and asthma in general medical practice. Chest. 1999, 115: 1259-64. 10.1378/chest.115.5.1259.View ArticleGoogle Scholar
- Fishwick D, Pearce N, D'Souza W, Lewis S, Town I, Armstrong R, Kogevinas M, Crane J: Occupational asthma in New Zealanders: a population based study. Occup Environ Med. 1997, 54: 301-6.View ArticleGoogle Scholar
- Kogevinas M, Anto JM, Soriano JB, Tobias A, Burney P: The risk of asthma attributable to occupational exposures. Am J Respir Crit Care Med. 1996, 154: 137-43.View ArticleGoogle Scholar
- Sunyer J, Kogevinas M, Kromhout H, Anto JM, Roca J, Tobias A, Vermeulen R, Payo F, Maldonado JA, Martinez-Moratalla J, Muniozguren N: Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Spanish Group of the European Community Respiratory Health Survey. Am J Respir Crit Care Med. 1998, 157: 512-7.View ArticleGoogle Scholar
- Bradshaw LM, Fishwick D, Slater T, Pearce N: Chronic bronchitis, work related respiratory symptoms, and pulmonary function in welders in New Zealand. Occup Environ Med. 1998, 55: 150-4.View ArticleGoogle Scholar
- Bakke S, Baste V, Hanoa R, Gulsvik A: Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax. 1991, 46: 863-70.View ArticleGoogle Scholar
- Chan-Yeung M, Malo JL: Aetiological agents in occupational asthma. Eur Respir J. 1994, 7: 346-71. 10.1183/09031936.94.07020346.View ArticleGoogle Scholar
- Fabbri LM, Maestrelli P, Saetta M, Mapp CM: Mechanisms of occupational asthma. Clin Exp Allergy. 1994, 24: 628-35.View ArticleGoogle Scholar
- Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS: Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax. 2002, 57: 231-6. 10.1136/thorax.57.3.231.View ArticleGoogle Scholar
- Balmes JR: Occupational airways diseases from chronic low-level exposures to irritants. Clin Chest Med. 2002, 23: 727-35.View ArticleGoogle Scholar
- Viegi G, Di Pede C: Chronic obstructive lung diseases and occupational exposure. Curr Opin Allergy Clin Immunol. 2002, 2: 115-21. 10.1097/00130832-200204000-00006.View ArticleGoogle Scholar
- De Zotti R, Larese F, Bovenzi M, Negro C, Molinari S: Allergic airway disease in Italian bakers and pastry makers. Occup Environ Med. 1994, 51: 548-52.View ArticleGoogle Scholar
- Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL: Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med. 2001, 163: 899-904.View ArticleGoogle Scholar
- Talini D, Monteverdi A, Benvenuti A, Petrozzino M, Di Pede F, Lemmi M, Carletti A, Macchioni P, Serretti N, Viegi G, Paggiaro P: Asthma-like symptoms, atopy, and bronchial responsiveness in furniture workers. Occup Environ Med. 1998, 55: 786-91.View ArticleGoogle Scholar
- Romano C, Sulotto F, Piolatto G, Ciacco C, Capellaro E, Falagiani P, Constable DW, Verga A, Scansetti G: Factors related to the development of sensitization to green coffee and castor bean allergens among coffee workers. Clin Exp Allergy. 1995, 25: 643-50.View ArticleGoogle Scholar
- Ucgun I, Ozdemir N, Metintas M, Metintas S, Erginel S, Kolsuz M: Prevalence of occupational asthma among automobile and furniture painters in the center of Eskisehir (Turkey): the effects of atopy and smoking habits on occupational asthma. Allergy. 1998, 53: 1096-100.View ArticleGoogle Scholar
- Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ: Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study. Occup Environ Med. 1998, 55: 684-91.View ArticleGoogle Scholar
- Zetterstrom O, Osterman K, Machado L, Johansson SG: Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br Med J. 1981, 283: 1215-7.View ArticleGoogle Scholar
- Kogevinas M, Anto JM, Soriano JB, Tobias A, Burney P: The risk of asthma attributable to occupational exposures. A population-based study in Spain. Spanish Group of the European Asthma Study. Am J Respir Crit Care Med. 1996, 154: 137-43.View ArticleGoogle Scholar
- Zock JP, Sunyer J, Kogevinas M, Kromhout H, Burney P, Anto JM: Occupation, chronic bronchitis, and lung function in young adults. An international study. Am J Respir Crit Care Med. 2001, 163: 1572-7.View ArticleGoogle Scholar
- Burney PG, Luczynska C, Chinn S, Jarvis D: The European Community Respiratory Health Survey. Eur Respir J. 1994, 7: 954-60.View ArticleGoogle Scholar
- Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983, 19 (Suppl 5): 1-95.
- Pearce N: Analytical implications of epidemiological concepts of interaction. Int J Epidemiol. 1989, 18: 976-80.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.